Contract Services Pre-Clinical Outsourcing
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...
October 28, 2021 | News
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
360biolabs®, the most comprehensive contract research organization in Australia and New Zealand, has now officially joined forces with BioAgilytix Labs...
October 14, 2021 | News
Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease
News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...
October 11, 2021 | News
Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021
Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...
September 23, 2021 | News
WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...
September 15, 2021 | News
NeuExcell to reach the full potential of their innovative gene technology platform on accelerated timelines
FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell'...
September 13, 2021 | News
Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine
First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...
September 11, 2021 | News
Odyssey Group Approved to Start Human Trial to Treat Concussion
The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...
September 08, 2021 | News
WuXi Biologics Received First Manufacturing License from Japan
WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...
September 02, 2021 | News
InxMed's IN10018 Receives U.S. FDA Fast Track Designation
InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with inte...
August 16, 2021 | News
Antengene & MindRank AI to jointly develop first-in-class small-molecule oncology drugs
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...
August 09, 2021 | News
Clarivate Acquires Bioinfogate
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...
August 05, 2021 | News
Nanoform and Boehringer Ingelheim execute master services agreement
The two parties have executed a master services agreement (MSA) to initiate projects in the pre-clinical early development space with the aim of ...
August 04, 2021 | News
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate
This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...
August 03, 2021 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
